from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3081/-

LFCtreatmentdescriptionclass of inhibitor

0.652

Amikacinug/mL Amikacintranslation

0.295

Cap5-10ug/mL Capreomycintranslation

-0.208

Rox10-50 ug/mL Roxithromycintranslation

-0.099

SM2-5 ug/mL Streptomycintranslation

-1.059

Tet5-10 ug/mL Tetracyclinetranslation

1.161

Rif0.2-5ug/mL Rifampicintranscription

-1.094

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.920

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.215

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.085

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.183

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.377

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.164

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.570

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.278

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.735

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.401

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.174

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.556

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.041

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.424

KCN5-20 ug/mL Potassium cyaniderespiration

-0.534

NaN30.2-2 mM Sodium aziderespiration

-0.624

Nigericin50 uM Nigericinrespiration

-0.134

TRC10-150 ug/mL Triclosanrespiration

0.168

TRZ10-25 ug/mL Thioridazinerespiration

0.283

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.932

menadione6-10 ug/mL Menadionerespiration

-0.185

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.235

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.804

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.726

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.591

NRP_1Non-replicating persistence stage 1dosRassociated

-0.263

Amp0.2mg/mL AmpicillincellWall

0.066

Cephalexin20-100 ug/mL CephalexincellWall

0.485

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.021

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.538

EMB10-20 ug/mL EthambutolcellWall

-0.395

Eta12-40 ug/mL EthionamidecellWall

-1.149

INH0.2-0.4 ug/mL IsoniazidcellWall

0.127

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.368

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.227

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.884

BZA0.12 mg/mL BenzamidearomaticAmides

0.260

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.536

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.234

H2O24 mM hydrogen peroxideDNAdamaging

0.060

Levo10 ug/mL LevofloxacinDNAdamaging

-0.274

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.042

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.201

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.015

UVUV-irradiationDNAdamaging

0.437

ARP41-4 ug/mL Antitubercular compound ARP4?

1.057

Antimycin12.5-50 ug/mL Antimycin A?

-0.454

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.081

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.264

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.514

PA8240.2-2 ug/mL PA-824?

-0.693

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.350

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.494

Verapamil50 uM Verapamil?

-0.167

mercaptoethanol2 mM 2-Mercaptoethanol?

0.219

methoxatin10-20 ug/mL Methoxatin?